About 517,000 results
Open links in new tab
  1. PDL1 (Immunotherapy) Tests: MedlinePlus Medical Test

    A PD-L1 test uses a sample of cancerous tumor tissue to measure how much of a protein called PD-L1 is found on the cancer cells. If you have certain types of cancer, PD-L1 testing can …

  2. PD-L1 Testing | Choose the Right Test - ARUP Consult

    4 days ago · How do I determine the appropriate programmed death-ligand 1 (PD-L1) test to order? Selection of the appropriate test depends on the patient’s malignancy and the intended …

  3. PD-L1: Test Selection Guide | Test Guide | Quest Diagnostics

    This Test Guide provides an overview of the use of tests for PD-L1 and other biomarkers involved in selection of PD-1/PD-L1 inhibitor therapy.

  4. What does it mean to have PD-L1 positive What does it mean to have PD-L1 positive (PD-L1+) Lung Cancer?

  5. PD-L1 Testing | Labcorp Oncology

    Overexpression of PD-L1 has been observed in many carcinomas including lung, urinary bladder, and gastroesphageal junction.

  6. PD-L1 Testing Information | KEYTRUDA® (pembrolizumab) | HCP

    Health care professionals may find information about PD-L1 testing, and how to evaluate PD-L1 expression based on combined positive score (CPS) and tumor proportion score (TPS).

  7. PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among …

    Here we report the findings for PD-L1 testing, first-line treatment patterns, and clinical outcomes after first-line therapy initiation for patients with metastatic NSCLC at an academic medical …

  8. PD-L1, PD1,TMB and Lung Cancer | American Lung Association

    Dec 9, 2025 · A PD-L1 test is reported as a percentage, measuring how much cells in a tumor “express” PD-L1. Tumors that express high amounts of PD-L1 (50% or greater) may respond …

  9. What Is the PDL1 IHC Test for Cancer Treatment?

    Jul 26, 2025 · The PD-L1 IHC test serves as an important tool in cancer care, providing insights into a tumor’s characteristics. This test helps medical professionals understand how a tumor …

  10. Evaluating Immune Checkpoint Inhibition Biomarkers

    Aug 6, 2020 · A number of anti-PD-1/PD-L1 therapies are available for different cancer indications. This resource aims to provide an overview of the benefits and limitations of …